Taxus Cardium Pharmaceuticals Group Owners

Health Care & Life Sciences » Biotechnology | Taxus Cardium Pharmaceuticals Group Inc.

Taxus Cardium Pharmaceuticals Group Inc. | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Sabby Capital LLC

1,435,917

9.99%

64,935

0.06%

12/31/2017

Invesco Capital Management LLC

2,864

0.02%

09/05/2018

View Profile

Address	11750 Sorrento Valley Road San Diego California 92121 United States
Employees	-
Website	http://www.cardiumthx.com
Updated	07/08/2019
Taxus Cardium Pharmaceuticals Group, Inc. is regenerative therapeutics company . The company focuses on the late-stage clinical and development of regenerative medicine therapeutics. Its product candidates include Generx, an interventional cardiology, angiogenic gene therapy product candidate designed for the treatment of cardiac microvascular insufficiency due to increasing coronary artery disease; and Excellagen, an acellular biological skin substitute designed as a wound care product for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers.